Professor Toth is a Chemical Engineer with a research focus on medicinal chemistry. He was awarded his Ph.D. in 1972 and has since worked in Hungary, Canada, and the United Kingdom before relocating to Australia in 1998. His major research interests are drug delivery, immunoadjuvants, synthetic vaccines, and gene delivery. His research has attracted over AUD 60 million in competitive grants, research contracts, and investment funds in the past 10 years. He has over 300 peer-reviewed publications, 43 patents, and an excellent track record in research commercialization as a key founder of Alchemia (ASX listed), Implicit Bioscience Pty Ltd., Neurotide Pty Ltd., and TetraQ (the commercial arm of the Centre of Integrated Preclinical Drug Development).
Well done!
